MC1422A1 - Derives acyles - Google Patents

Derives acyles

Info

Publication number
MC1422A1
MC1422A1 MC811552A MC1552A MC1422A1 MC 1422 A1 MC1422 A1 MC 1422A1 MC 811552 A MC811552 A MC 811552A MC 1552 A MC1552 A MC 1552A MC 1422 A1 MC1422 A1 MC 1422A1
Authority
MC
Monaco
Prior art keywords
compound
salts
oxo
group
starting compounds
Prior art date
Application number
MC811552A
Other languages
English (en)
French (fr)
Inventor
Roland Reiner
Urs Weiss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1422A1 publication Critical patent/MC1422A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D293/00Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms
    • C07D293/02Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms not condensed with other rings
    • C07D293/04Five-membered rings
    • C07D293/06Selenazoles; Hydrogenated selenazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MC811552A 1980-10-10 1981-10-08 Derives acyles MC1422A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH758380 1980-10-10
CH533581 1981-08-18

Publications (1)

Publication Number Publication Date
MC1422A1 true MC1422A1 (fr) 1982-10-18

Family

ID=25697488

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811552A MC1422A1 (fr) 1980-10-10 1981-10-08 Derives acyles

Country Status (15)

Country Link
US (2) US4458072A (cs)
EP (1) EP0049855B1 (cs)
JP (1) JPH0242071A (cs)
AU (1) AU7602381A (cs)
CA (1) CA1177824A (cs)
DE (1) DE3173643D1 (cs)
DK (1) DK449981A (cs)
ES (2) ES506142A0 (cs)
FI (1) FI813125L (cs)
GR (1) GR75075B (cs)
IL (1) IL63965A (cs)
MC (1) MC1422A1 (cs)
NO (1) NO813420L (cs)
NZ (1) NZ198558A (cs)
PT (1) PT73799B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63965A (en) * 1980-10-10 1985-01-31 Sparamedica Ag 7-(2-(2-amino-4-selenazoyl)acetamido)cephalosporin derivatives,and intermediates therefor,their preparation and pharmaceutical compositions containing them
US4680408A (en) * 1980-10-10 1987-07-14 Hoffmann-La Roche Inc. Acyl derivatives
DK163000C (da) * 1982-09-30 1992-06-01 Shionogi & Co Analogifremgangsmaade til fremstilling af vinylthioacetamido-1-dethia-1-oxa-cephalosporinderivater
JP2595605B2 (ja) * 1988-01-18 1997-04-02 武田薬品工業株式会社 2−置換オキシイミノ−3−オキソ酪酸の製造法
AU3967000A (en) * 1999-04-15 2000-11-02 Biochemie Gesellschaft Mbh Beta-lactam production
AT411598B (de) * 1999-04-29 2004-03-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinen
AT408225B (de) * 1999-04-29 2001-09-25 Biochemie Gmbh Verfahren zur herstellung von cephalosporinen
CA2536910A1 (en) * 2003-08-25 2005-03-10 Revaax Pharmaceuticals, Llc Oral neurotherapeutic cefazolin compositions
US20050119244A1 (en) * 2003-12-02 2005-06-02 Acs Dobfar S.P.A. Process for preparing cephalosporins with salified intermediate
US20110118462A1 (en) * 2009-11-18 2011-05-19 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory N-heterocyclic substituent-containing antibiotic, preparation and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
FR2346014A1 (fr) * 1976-01-23 1977-10-28 Roussel Uclaf Nouvelles oximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS609719B2 (ja) * 1977-08-06 1985-03-12 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
US4341775A (en) * 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
IL63965A (en) * 1980-10-10 1985-01-31 Sparamedica Ag 7-(2-(2-amino-4-selenazoyl)acetamido)cephalosporin derivatives,and intermediates therefor,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
PT73799A (en) 1981-11-01
US4458072A (en) 1984-07-03
NO813420L (no) 1982-04-13
ES512079A0 (es) 1983-10-16
EP0049855A2 (de) 1982-04-21
JPH0242071A (ja) 1990-02-13
AU7602381A (en) 1982-04-22
ES8301235A1 (es) 1982-12-01
GR75075B (cs) 1984-07-13
PT73799B (en) 1983-10-14
ES506142A0 (es) 1982-12-01
NZ198558A (en) 1985-08-16
US4593093A (en) 1986-06-03
FI813125A7 (fi) 1982-04-11
CA1177824A (en) 1984-11-13
EP0049855B1 (de) 1986-01-29
DE3173643D1 (en) 1986-03-13
EP0049855A3 (en) 1983-07-06
IL63965A (en) 1985-01-31
ES8400103A1 (es) 1983-10-16
IL63965A0 (en) 1981-12-31
FI813125L (fi) 1982-04-11
DK449981A (da) 1982-04-11

Similar Documents

Publication Publication Date Title
KR870000848B1 (ko) 세팔로스포린 유도체의 제조방법
CH634073A5 (en) 1,1-Dioxides of penicillanic acid and its esters which are useful as beta-lactamase inhibitors
MC1921A1 (fr) Derives acyles
MC1259A1 (fr) Derives acyles
MC1422A1 (fr) Derives acyles
FR2465737A1 (fr) 7-(2-(2-amino-4-thiazolyl)-2 - ((1-carboxy-1,1 - dialkyl)alcoxyimino)acetamido)cephem sulfoxydes a action antibacterienne
MC1833A1 (fr) Derives acyles
MC2021A1 (fr) Preparation de derives acyliques utilisables notamment pour la fabrication de medicaments
FR2569195A1 (fr) Derives du 7-carboxymethoxyphenylacetamido-3-cepheme utiles comme medicaments antibacteriens et procedes pour leur preparation
MC1970A1 (fr) Derives acyles
LU82429A1 (fr) Derives heterocycliques de cephalosporines oxy-imino-substituees
FR2478102A1 (fr) Nouveaux derives d'acide hydroxamique de ((amino-2 thiazolyl-4) oximino)-cephalosporines utiles notamment comme medicaments antibacteriens
EP0153229B1 (fr) Nouveaux dérivés de l'acide 1-déthia 2-thia céphalosporanique, leur procédé et leurs intermédiaires de préparation, leur application comme médicaments et les compositions les renfermant
CA1281319C (en) 2.beta.-SUBSTITUTED THIOMETHYLPENICILLIN DERIVATIVES AND THEIR PREPARATION AND USE
CA1271297A (fr) Derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2485016A1 (fr) Derives d'acide phosphonique de ((amino-2 thiazolyl-4) oximino)-7 cephalosporines, utiles notamment comme medicaments antibacteriens
LU82215A1 (fr) Procede et composes intermediaires pour la prouduction du 1,1-dioxyde d'acide penicillanique et de ses esters
MC2000A1 (fr) Derives acyles
FR2543958A1 (fr) Composes 2-thiacephem et procede pour les preparer
FR2583417A1 (fr) Acides 3-acylamino-2-oxo-1-azetidinesulfoniques a action therapeutique.
FR2465738A1 (fr) Sulfoxydes d'aminothiazolyl ureido cephalosporines a action antibacterienne, et procede et intermediaires permettant de les preparer
BE1007544A3 (fr) Derives de thioalkylthiocarbacephalosporines.
EP0298177A1 (fr) Nouveau procédé de préparation de dérivés de la pristinamycine IIB
FR2468608A1 (fr) Derives de la 1-oxadethiacephalosporine, leur procede de production et compositions anti-bacteriennes les contenant
EP0214029B1 (fr) Dérivés de l'acide l-déthia 2-thia céphalosporanique, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
YP Annual fee paid